KRYS insider buying and SEC filings, explained
Krystal Biotech, Inc. · CIK 1711279
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$8.2M
Planned sales (10b5-1)
$92.1M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 4, 2026 | Planned (10b5-1) | Suma Krishnan (President / COO and Director) sold 25,000 shares at about $359.32 ($9.0M), marked as a 10b5-1 plan trade. Holdings down 2% to 1,302,145 shares. | SEC filing Filed Sep 4, 2026 |
| Sep 4, 2026 | Planned (10b5-1) | Krish S Krishnan (CEO and Director) sold 25,000 shares at about $359.32 ($9.0M), marked as a 10b5-1 plan trade. Holdings down 2% to 1,347,543 shares. | SEC filing Filed Sep 4, 2026 |
| Aug 14, 2026 | Sale | Dino A. Rossi (Director) sold 25,000 shares at about $329.12 ($8.2M). Holdings down 33% to 50,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 14, 2026 |
| Jun 25, 2026 | Planned (10b5-1) | John Charles Thomas (EVP, General Counsel) sold 1,000 shares at $347.27 ($347K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | Suma Krishnan (President / COO and Director) sold 25,000 shares at about $308.12 ($7.7M), marked as a 10b5-1 plan trade. Holdings down 2% to 1,378,155 shares. | SEC filing Filed Jun 5, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | Krish S Krishnan (CEO and Director) sold 25,000 shares at about $308.12 ($7.7M), marked as a 10b5-1 plan trade. Holdings down 2% to 1,450,253 shares. | SEC filing Filed Jun 5, 2026 |
| May 26, 2026 | Planned (10b5-1) | John Charles Thomas (EVP, General Counsel) sold 642 shares at $302.03 ($194K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed May 27, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Suma Krishnan (President / COO and Director) sold 25,000 shares at about $263.21 ($6.6M), marked as a 10b5-1 plan trade. Holdings down 2% to 1,403,155 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Krish S Krishnan (CEO and Director) sold 25,000 shares at about $263.17 ($6.6M), marked as a 10b5-1 plan trade. Holdings down 2% to 1,475,253 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Kathryn Romano (Chief Accounting Officer) sold 750 shares at $267.60 ($201K), marked as a 10b5-1 plan trade. Holdings down 3% to 22,366 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 27, 2026 | Planned (10b5-1) | Daniel Janney (Director) sold 11,803 shares indirectly (by entity) at about $275.59 ($3.3M), marked as a 10b5-1 plan trade. Holdings by entity down 14% to 73,293 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 24–26, 2026 | Planned (10b5-1) | Daniel Janney (Director) sold 60,161 shares directly and indirectly (by entity) between Feb 24 and Feb 26 at about $268.44 ($16.1M), marked as a 10b5-1 plan trade. Direct holdings down 100% to 0 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 9, 2026 | Planned (10b5-1) | Kathryn Romano (Chief Accounting Officer) sold 12,500 shares at about $272.14 ($3.4M), marked as a 10b5-1 plan trade. Holdings down 39% to 19,318 shares. | SEC filing Filed Feb 11, 2026 |
| Dec 4, 2025 | Planned (10b5-1) | Suma Krishnan (President / COO and Director) sold 50,000 shares directly and indirectly (by spouse) at about $220.15 ($11.0M), marked as a 10b5-1 plan trade. Direct holdings down 2% to 1,413,711 shares. | SEC filing Filed Dec 5, 2025 |
| Dec 4, 2025 | Planned (10b5-1) | Krish S Krishnan (CEO and Director) sold 50,000 shares directly and indirectly (by spouse) at about $220.15 ($11.0M), marked as a 10b5-1 plan trade. Direct holdings down 2% to 1,483,056 shares. | SEC filing Filed Dec 5, 2025 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 7:07 AM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow KRYS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.